Age-related anatomical changes are most effectively managed through the combination of science and technology.
To achieve this goal, Neauvia research designed SMART COMBINATION THERAPY: an innovative synergistic approach which consists of a comprehensive system of protocols combining different medical aesthetic treatments and delivering optimal results. 1, 2
Created in 2012, distributed in more than 80 countries worldwide and today, Neauvia is a high growth multinational corporation with production sites and subsidiaries in Italy, Switzerland, France, Spain, Poland, Germany, UK and US.
Part of the MatexLab Group, which is backed by leading central European private equity firm Abris Capital, Neauvia is a pioneer in medical aesthetics and has developed ground-breaking synergistic smart combination therapies.
NEAUVIA SCIENTIFIC ACADEMY has been created to provide highest quality medical education by supporting healthcare professionals in the development of their practice and skills for better patients’ outcomes. One of the main objectives of the NEAUVIA SCIENTIFIC ACADEMY is to strengthen medical knowledge from product research to the effective use in daily practice.
We are pleased to announce LaserMe has received FDA Clearance, signifying a new key milestone for Neauvia development in the US.
24 Route de la Galaise
1228 Plan-les-Ouates
Geneve (Switzerland)
Regulations and usage conditions for products vary from market to market and the content on this page is not intended for US or Canadian audiences. This website is designed for informational purpose only. This information is not intended as a substitute for informed medical advice or recommendations from healthcare professionals. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider.
© 2023 Matex Lab S.p.a.
Powered by Glitchyframe
